These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21350191)

  • 1. Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice.
    Fourcot A; Couchie D; Chobert MN; Zafrani ES; Mavier P; Laperche Y; Brouillet A
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1043-53. PubMed ID: 21350191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice.
    Lafdil F; Chobert MN; Deveaux V; Zafrani ES; Mavier P; Nakano T; Laperche Y; Brouillet A
    J Hepatol; 2009 Jul; 51(1):55-66. PubMed ID: 19443073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
    Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
    Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
    Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
    J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
    Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
    Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
    Borkham-Kamphorst E; Drews F; Weiskirchen R
    Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice.
    Han J; Bae J; Choi CY; Choi SP; Kang HS; Jo EK; Park J; Lee YS; Moon HS; Park CG; Lee MS; Chun T
    Autophagy; 2016 Dec; 12(12):2326-2343. PubMed ID: 27780404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S; Wang J; Liu Q; Harnish DC
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
    Csak T; Velayudham A; Hritz I; Petrasek J; Levin I; Lippai D; Catalano D; Mandrekar P; Dolganiuc A; Kurt-Jones E; Szabo G
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
    Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
    Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.
    Beaven SW; Wroblewski K; Wang J; Hong C; Bensinger S; Tsukamoto H; Tontonoz P
    Gastroenterology; 2011 Mar; 140(3):1052-62. PubMed ID: 21134374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice.
    Ahsan MK; Okuyama H; Hoshino Y; Oka S; Masutani H; Yodoi J; Nakamura H
    Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
    Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
    Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.
    Syn WK; Jung Y; Omenetti A; Abdelmalek M; Guy CD; Yang L; Wang J; Witek RP; Fearing CM; Pereira TA; Teaberry V; Choi SS; Conde-Vancells J; Karaca GF; Diehl AM
    Gastroenterology; 2009 Oct; 137(4):1478-1488.e8. PubMed ID: 19577569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.